Reducing Packaging Costs for Prefilled Syringes
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.
Reducing Packaging Costs for Prefilled Syringes
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. Currently used for over-the-counter products, prescription medicines, and more than 50 injectable products, the authors present the case for using BFS for prefilled syringes. Factors including drug formulation, material compatibility, extractables and leachables, sterilization, and regulatory approval must be considered.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the authors
Beth Totin is chief commercial officer, and Marcus Webb is director of communications, both with ApiJect Systems, Corp.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 54–59
Citation
When referring to this article, please cite it as B. Totin and M. Webb, “Reducing Packaging Costs for Prefilled Syringes," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
